High prevalence of extended-spectrum-cephalosporin-resistant Enterobacteriaceae in poultry meat in switzerland: Emergence of CMY-2- and VEB-6-possessing Proteus mirabilis

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 12, 2013, Pages 6406-6408

  Seiffert, Salome N ^a   Tinguely, Regula ^a   Lupo, Agnese ^a   Neuwirth, Catherine ^b   Perreten, Vincent ^a   Endimiani, Andrea ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN; PALINDROMIC DNA;

ANTIBIOTIC RESISTANCE; BACTERIUM COLONY; BACTERIUM ISOLATE; ELECTROPORATION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FOOD CHAIN; INTEGRON; LETTER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEAT; NONHUMAN; NUCLEOTIDE SEQUENCE; POULTRY; PRIORITY JOURNAL; PROTEUS MIRABILIS; SWITZERLAND;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; POULTRY; PREVALENCE; SWITZERLAND;

EID: 84887466532     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01773-13     Document Type: Letter

References (14)

1. Kola A, Kohler C, Pfeifer Y, Schwab F, Kuhn K, Schulz K, Balau V, Breitbach K, Bast A, Witte W, Gastmeier P, Steinmetz I. 2012. High prevalence of extended-spectrum-β-lactamase-producing Enterobacteriaceae in organic and conventional retail chicken meat, Germany. J. Antimicrob. Chemother. 67:2631-2634.
2. Egea P, Lopez-Cerero L, Torres E, del Gomez-Sanchez MC, Serrano L, Navarro Sanchez-Ortiz MD, Rodriguez-Bano J, Pascual A. 2012. Increased raw poultry meat colonization by extended spectrum β-lactamase- producing Escherichia coli in the south of Spain. Int. J. Food Microbiol. 159:69-73.
3. Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J, Voets GM, van den Munckhof MP, van Essen-Zandbergen A, Platteel T, Fluit AC, van de Sande-Bruinsma N, Scharinga J, Bonten MJ, Mevius DJ. 2011. Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin. Microbiol. Infect. 17:873-880.
4. Seiffert SN, Hilty M, Kronenberg A, Droz S, Perreten V, Endimiani A. 2013. Extended-spectrum cephalosporin-resistant Escherichia coli in community, specialized outpatient clinic and hospital settings in Switzerland. J. Antimicrob. Chemother. 68:2249-2254.
5. Hilty M, Betsch BY, Bögli-Stuber K, Heiniger N, Stadler M, Kuffer M, Kronenberg A, Rohrer C, Aebi S, Endimiani A, Droz S, Mühlemann K. 2012. Transmission dynamics of extended-spectrum β-lactamaseproducing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin. Infect. Dis. 55:967-975.
6. Endimiani A, Rossano A, Kunz D, Overesch G, Perreten V. 2012. First countrywide survey of third-generation cephalosporin-resistant Escherichia coli from broilers, swine, and cattle in Switzerland. Diagn. Microbiol. Infect. Dis. 73:31-38.
7. Zong Z, Partridge SR, Iredell Jr. 2009. A blaVEB-1 variant, blaVEB-6, associated with repeated elements in a complex genetic structure. Antimicrob. Agents Chemother. 53:1693-1697.
8. Seiffert SN, Hilty M, Perreten V, Endimiani A. 2013. Extendedspectrum cephalosporin-resistant gram-negative organisms in livestock: an emerging problem for human health? Drug Resist. Updat. 16:22-45.
9. Woodford N, Turton JF, Livermore DM. 2011. Multiresistant Gramnegative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. 35:736-755.
10. Endimiani A, Hilty M, Perreten V. 2012. CMY-2-producing Escherichia coli in the nose of pigs. Antimicrob. Agents Chemother. 56:4556-4557.
11. D'Andrea MM, Literacka E, Zioga A, Giani T, Baraniak A, Fiett J, Sadowy E, Tassios PT, Rossolini GM, Gniadkowski M, Miriagou V. 2011. Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe. Antimicrob. Agents Chemother. 55:2735-2742.
12. Siebor E, Neuwirth C. 2011. The new variant of Salmonella genomic island 1 (SGI1-V) from a Proteus mirabilis French clinical isolate harbours blaVEB-6 and qnrA1 in the multiple antibiotic resistance region. J. Antimicrob. Chemother. 66:2513-2520.
13. Potron A, Poirel L, Elhag K, Al Yaqoubi F, Nordmann P. 2009. VEB-6 extended-spectrum β-lactamase-producing Proteus mirabilis from Sultanate of Oman. Int. J. Antimicrob. Agents 34:493-494.
14. EUCAST. 2013. European Committee on Antimicrobial Susceptibility Testing clinical breakpoints. Version 3.0.